Key Highlights
- 35% lower total care costs for CGM patients using medical benefits over pharmacy.
- 23% higher adherence to CGM therapy through medical benefit.
- CCS presented findings at ADCES and ISPOR conferences.
- AI-powered PropheSee™ model boosts patient adherence by up to 50%.
Source: Business Wire
Notable Quotes
- “CGMs are only effective if people use them. This first-of-its-kind research demonstrates that a physician’s decision to direct a patient to use their medical benefit instead of their pharmacy benefit when accessing a medical device can seriously impact health outcomes and costs of care.” — Dr. Arti Masturzo, Chief Medical Officer at CCS
- “They’ve coached me on how to use a CGM and helped educate me on the value of using my medical benefit.” — Scott Gerberich, Patient
SoHC's Take
The research from CCS underscores the importance of ensuring that patients access continuous glucose monitoring (CGM) devices through their medical benefits instead of pharmacy benefits. The data-driven insights highlight significant cost savings and improved adherence, which are crucial for both patient outcomes and healthcare sustainability. CCS’s integration of education, coaching, and AI-driven predictive tools further cements its role as a leader in chronic care management, particularly for diabetes care. With rising CGM adoption and an urgent need for effective patient support, CCS’s innovations, like PropheSee™, offer a promising model for the future of proactive chronic care management.
Heading
Episode Details: Dental Financial Solutions Join us on this week's episode of our new Dental focused show, hosted by Jared ...
Key Highlights $11.5M Series A funding led by Construct Capital with participation from GC 1 Capital, One Way Ventures, and 2048 ...
Key Highlights Tabia Health integrates American Heart Association CarePlans into its AI-powered healthcare orchestration platform. Joins the American Heart Association Center ...
Key Highlights Heyward Donigan appointed CEO of Health Network One beginning January 1, 2025. Luis Mosquera transitions to Executive Chairman, focusing on strategic growth. Donigan ...
Key Highlights $31.5 million Series B funding led by Oak HC/FT, backed by Y Combinator, Reach Capital, and more. Programs for ...
Key Highlights Patterson Dental extends partnership with PDS Health until 2027. Agreement secures Patterson as PDS Health’s premier distributor for technology, equipment, and services. Over ...
